[ 18 F]MPPF is a selective serotonin-1A (5-HT 1A ) receptor antagonist and may be used to measure changes in the functional levels of serotonin (5-HT). The technique is based on the assumption that the injected radiolabeled ligand competes for the same receptor as the endogenous transmitter. Results from studies using serotonergic ligands are not always consistent. The aim of the present study was to investigate if [
INTRODUCTION
The serotonergic system has been implicated in the pathophysiology and treatment of a variety of psychiatric disorders such as depression, anxiety, and schizophrenia (Blier and de Montigny, 1998; den Boer, 2000; Kapur and Remington, 2001; Seeman, 2002) . Several studies reported the possible involvement of the 5-HT 1A receptor in these disorders (Bantick et al, 2001; Groenink et al, 2003; Hjorth et al, 2000) . Differences in receptor densities can be quantified using radiolabeled ligands. The selective 5-HT 1A receptor antagonists [ -methyl-3H ]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride) appear to be useful radioligands for imaging of the 5-HT 1A receptor in human subjects (Andree et al, 2000; Passchier et al, 2000; Sargent et al, 2000) .
Previous studies have shown that radiolabeled ligands could also be used to measure changes in the functional level of neurotransmitters in the brain. Abnormalities in 5-HT transmission have been widely studied using neuroendocrine challenge studies (Power and Cowen, 1992) . This method, however, only reflects functioning of the hypothalamo-hypophysial serotonergic system, but does not necessarily assess 5-HT transmission in other brain regions. The combined use of radiolabeled ligands with a serotonergic challenge may provide information on 5-HT release in specific regions of the brain. The approach is based on the assumption that an injected radiolabeled ligand competes for the same receptor as the endogenous transmitter. So, increases in neurotransmitter release result in a decreased binding of the radioligand and decreased neurotransmitter release induces an increase in ligand binding. The changes in ligand binding are used as a measure of the change in neurotransmitter levels. This method has successfully been used for the dopaminergic system (Breier et al, 1997; Laruelle, 2000) . Results from studies using serotonergic ligands, however, do not always agree. Haes et al, 2002) .
The lack of effect in the studies that manipulated tryptophan levels may have been caused by the fact that intrasynaptic 5-HT levels are not sufficiently changed to produce a measurable effect on ligand binding (Rabiner et al, 2002; Udo de Haes et al, 2002) . The differences in the studies using fenfluramine may be related to differences in timing of the pharmacological treatment. Another important factor could be the use of anesthesia. Previous studies have shown that ligand binding may be affected by the use of different anesthetics. The mechanism of these effects is not completely understood but may be related to changes in cerebral blood flow or receptor affinity (Ginovart et al, 2002; Harada et al, 2004; Hassoun et al, 2003; Seeman and Kapur, 2003) . The size of 5-HT increase may also differ between conscious and anesthetized rats (Mokler et al, 1998) .
In the present study we investigated the effect of fenfluramine (10 mg/kg, i.p.) and of a combination of the SSRI citalopram with the 5-HT 2C antagonist ketanserin. Microdialysis studies in rat have shown that both treatments induce marked increases in extracellular 5-HT concentrations. The effect of the combined treatment of citalopram with ketanserin may be caused by a combination of 5-HT reuptake inhibition and modulation of global or local feedback mechanism(s), resulting in increased 5-HT release (Cremers et al, 2004) . Since, as mentioned before, anesthetics may have confounding effects on ligand binding, we used conscious rats. The effects on [ 18 F]MPPF binding were investigated using ex vivo autoradiography. Concurrently, the effect of both challenges on extracellular 5-HT concentration was studied using similar dosages in microdialysis experiments.
MATERIALS AND METHODS

Animals
Male Wistar rats weighing 250-350 g (Harlan, Zeist, The Netherlands) were used. After surgery (see below), rats were housed individually and kept on a 12-h light/dark schedule with food and water ad libitum. Microdialysis and ex vivo autoradiography experiments were carried out in separate animal groups. During microdialysis sampling and radioligand injection, rats were in conscious condition and able to move freely in their cages. All experiments were carried out during the light period. The study was approved by the Animal Care Committee of the University of Groningen. Shiue et al (1997) for a comparable method). It was formulated into a 5% NaCl solution. Levels of nitro precursor were oo1 mg/l. The radiochemical purity was greater than 95% and the specific activity 410 TBq/mmol at the time of injection.
Synthesis of
Ex Vivo Autoradiography
Jugular veins were cannulated 24-48 h prior to radioligand injection (for a detailed description of the cannulation method, see Steffens (1969) , for details on anesthesia during cannulation, see microdialysis experiments). At 2 h before radioligand injection, the animals were deprived of food. Rats were injected with [
18 F]MPPF via the jugular vein cannula, in conscious condition. The mean (7SD) injected activity and injected mass were 14.4 (75.8) MBq and 0.23 (70.07) nmol, respectively, and did not significantly differ between groups. At 30 min prior to radioligand injection, the animals were treated either with saline (n ¼ 7), fenfluramine (10 mg/kg, i.p.) (n ¼ 7), or a combination of citalopram (10 mmol/kg, s.c.) with ketanserin (100 nmol/kg, s.c.) (n ¼ 5). The animals were killed by rapid guillotine decapitation (no anesthesia) 30 min after [
18 F]MPPF administration. This time point is based on earlier studies which showed that 30 min after injection, MPPF binding reaches a state of transient equilibrium (Plenevaux et al, 2000b; Shiue et al, 1997) . The brains were removed from the skull, frozen in isopentane (À801C), cut into 80 mm coronal slices in a cryostat at -101C, thaw mounted onto glass slides, exposed to a phosphor storage screen (Packard) for at least 10 halflife times (18-20 h) and scanned using the Cyclone storage phosphor system. Regions of interest (ROIs) were drawn around the frontal cortex, cingulate cortex, septal nuclei, caudate-putamen (striatum), thalamus, hypothalamus, dentate gyrus, interpeduncular nucleus, amygdala, hippocampus, dorsal raphe, and median raphe, using the Paxinos and Watson brain atlas (Paxinos and Watson, 1998) . For each region, data from the four sections with the highest activity were averaged, except for the amygdala, interpeduncular nucleus, and raphe where an average of two sections was used. For quantification, the digital light units (DLU)/mm 2 values were measured for the different ROIs. Individual calibration standards with known activity were exposed to the screen simultaneously with the brain slices to convert the DLU/mm 2 values to Bq/mm 2 . The activity of the different regions was converted to % injected dose per gram tissue (%ID) by dividing the regional activity by the injected activity and thickness of the slice. Specific binding was defined by the activity ratio of the region of interest to the cerebellum, a region virtually devoid of 5-HT 1A receptors (Hall et al, 1997) .
Microdialysis Experiments
Preceding surgery, rats were anesthetized by means of isoflurane 2%, 600 ml/min O 2 , and 400 ml/min N 2 O. Microdialysis probes were inserted in the ventral hippocampus (L þ 4.8 mm, IA: þ 3.7 mm, V: À8.0 mm) and dorsal raphe nucleus (L À1.4 mm, IA: þ 1.2 mm, V: À7.0 mm angle 101). Sample collection was performed 24-48 h after surgery, in conscious condition. The animals were treated either with fenfluramine (10 mg/kg, i.p.) (n ¼ 4 in the ventral hippocampus) or a combination of citalopram (10 mmol/kg, s.c.) with ketanserin (100 nmol/kg, s.c.) (n ¼ 4 in the ventral hippocampus and raphe nucleus). The probes were perfused with artificial cerebrospinal fluid containing (in mM): NaCl 147, KCl 3.0, CaCl 2 1.2, and MgCl 2 1.2, at a flow-rate of 1.5 l/m). Microdialysis samples (15-minute) were collected and 5-HT levels were measured by HPLC with electrochemical detection. Post mortem, the position of the probe was verified by the track of the probe through the brain. Data are expressed as percent baseline. For a more detailed description of the microdialysis experiments and serotonin analysis, see Cremers et al (2004) .
Behavioral Observation
The animals were continuously observed after injection of the pharmacological treatments, and effects on body movements or posture were scored as present if occurring during the observation period.
Statistics
The effects of the different treatments on [ 18 F]MPPF binding were analyzed by an independent samples t-test. The data are presented as mean ratio to cerebellum (7SD) and % change compared to control rats. Bonferroni corrections were used in order to correct for multiple comparisons.
Drugs
Citalopram hydrobromide and racemic fenfluramine hydrochloride were synthesized at and obtained from Lundbeck A/S (Copenhagen, Denmark). Ketanserin was obtained from RBI (Natick, USA). All drugs were dissolved in saline.
RESULTS
Microdialysis
Fenfluramine (10 mg/kg, i.p.) administration induced a 25-fold increase in the hippocampus at 45 min postinjection. 5-HT levels were maximal at 60 min after administration. At that time, a 30-fold increase in 5-HT levels was observed. After combined administration of citalopram (10 mmol/kg, s.c.) and ketanserin (100 nmol/kg, s.c.), a 10-fold increase in 5-HT was observed in the ventral hippocampus and a fivefold increase in the raphe nucleus. Peak levels were achieved 45 min after administration (Figure 1 ). uptake in the raphe nuclei, septum, and hippocampus and low uptake in the cerebellum (Ginovart et al, 2000; Passchier et al, 2000; Plenevaux et al, 2000a; Shiue et al, 1997) . Region over cerebellum ratios ranged from approximately 1 in the striatum to around 10 in the dorsal raphe nucleus.
Ex Vivo Autoradiography
Effect of fenfluramine pretreatment. Administration of fenfluramine did not significantly affect cerebellar [
18 F]MPPF binding, compared to control rats. In fenfluramine-treated rats, mean (7 SD) radioactivity in the cerebellum was 0.028 (70.017) %ID, compared to 0.030 (70.010) %ID in control rats. Figure 2 depicts an example of a phosphor screen image at the level of the hippocampus and cerebellum of a control and fenfluramine-treated rat, showing that [
18 F]MPPF binding is reduced in the fenfluramine-treated rat compared to the control rat. In Table 1 and Figure 3, 
Effects on Behavior
Fenfluramine administration resulted in hind leg abduction, straub tail, penile licking, and increased respiration. After administration of ketanserin and citalopram, penile erections were observed and an increase in grooming and licking behavior. Effects were seen at the time of % change refers to drug-versus saline-treated rats. *Indicates significant difference compared to control rats (po0.05, two-tailed t-test with Bonferroni correction). **Indicates significant difference compared to control rats (po0.01, two-tailed t-test with Bonferroni correction). 
DISCUSSION
The aim of this study was to investigate if [ Previous ex vivo dissection studies in nonanesthetized and anesthetized animals (Hume et al, 2001; Maeda et al, 2001 , respectively) did not show a significant effect of fenfluramine on the distribution of [ 11 C]WAY-100635. However, in both studies, a nonsignificant reduction in radioactivity content was seen in several brain areas, comparable to the regions in our study. The differences in effect size between our study and their studies may be explained by differences in method or timing of the pharmacological challenge. In our study, the animals were killed at the time of the peak in 5-HT concentration, whereas in the studies of Maeda et al (2001) and Hume et al (2001) , the animals were killed before or after the peak in 5-HT response, respectively. Using PET, Hume et al (2001) reported a 20% reduction in [ 11 C]WAY-100635 binding potential in the hippocampus after 10 mg/kg fenfluramine, a reduction comparable to that seen in our study. Using the same ligand as used in our study, the group of Zimmer studied the effect of changes in 5-HT levels by administration of different doses of fenfluramine (Zimmer et al, 2002a, b) . [ 18 F]MPPF binding was studied in anesthetized rats using a b þ radiosensitive probe. The effect of fenfluramine in their study was much larger than the effect as reported in our study. In the studies of Zimmer et al, a complete displacement of [ 18 F]MPPF was seen after an injection of 10 mg/kg fenfluramine. And even after lower doses of fenfluramine, reductions of 25-60% were seen. (2002a, b) could be attributed to its lower affinity. Although the exact reason for the discrepancies between our study and the group of Zimmer is not clear, it may be due to methodological factors. The group of Zimmer investigated the effects on [
18 F]MPPF binding using a b þ radiosensitive probe, which is an invasive instrument and also sensitive to methodological errors (Ginovart et al, 2004) . Previous autoradiography and PET studies using dopaminergic ligands have reported reductions in radioligand binding in the same order as in our study (for a review, see Laruelle, 2000) .
Before attributing the effects of fenfluramine on [ 18 F]MPPF binding to an increase in intrasynaptic 5-HT release, we should also consider other possibilities to explain our results. The effect of fenfluramine in our study could have been caused by direct binding of this drug to the 5-HT 1A receptor; however, this is not very likely since the affinity of fenfluramine for the 5-HT 1A receptor is very low (mM range) (Mennini et al, 1991) . Furthermore, the pharmacological treatments may have affected nonspecific binding. However, this would have caused changes in cerebellar activity, which is not significantly affected in our study. Increases in 5-HT levels may also have an effect on regional cerebral blood flow (Cohen et al, 1996) (McBean et al, 1999) . Therefore, the effect of fenfluramine in our study may indeed be explained by a reduced 5-HT 1A receptor availability, due to an increase in intrasynaptic 5-HT levels.
The binding of [ 18 F]MPPF was not affected by combined administration of citalopram and ketanserin. After administration of fenfluramine, a 30-fold increase in extracellular 5-HT levels was found, whereas administration of the combination only resulted in a 10-fold increase in 5-HT levels. Previous studies have shown that extracellular levels do not always reflect intrasynaptic processes (Tsukada et al, 2000a, b) . The 5-HT 1A receptors are located both within the synapse and extrasynaptically (Azmitia et al, 1996; Riad et al, 2000) . In a previous study using [ 18 F]MPPF, we concluded that changes in the binding of this ligand mainly reflect changes in intrasynaptic 5-HT levels, since, at least in postsynaptic areas, the proportion of extrasynaptic receptors is assumed to be low (Udo de Haes et al, 2002) . The two treatments used in our study may have differently affected 5-HT levels at the intrasynaptic 5-HT 1A receptor due to their different regulation of 5-HT release and reuptake.
If we assume, however, that the extracellular 5-HT levels are a reflection of the intrasynaptic levels, our results may also be explained by the difference in the magnitude of the 5-HT increase. The effect of an increase in 5-HT on ligand binding can be calculated using the standard competition formula that relates the bound radiotracer (B) to the receptor density (B max ), the radioligand K D , and free radioligand (L) in the presence of a competitor such as 5-HT, present at concentration F 5ÀHT and with an affinity 1999) . When the ligand is administered at a tracer dose, L is negligible compared to K D . Neglecting L in the denominator, and defining the binding potential (BP) before and after the serotonergic challenge as BP 1 and BP 2 , F 5ÀHT1 and F 5ÀHT2 as the free 5-HT concentrations before and after the challenge, respectively, the relative reduction of BP induced by the challenge can be calculated as follows:
The relative change in BP induced by the change in F 5ÀHT , will be independent of K D , as this factor cancels out. The 5-HT 1A receptor can exist in a high-and low-affinity state (Khawaja, 1995; Watson et al, 2000) . In our calculations, we used 5-HT K i values of 5 and 250 nM for the high-and low-affinity state, respectively (Watson et al, 2000) and a baseline extracellular 5-HT concentration of 0.9 nM (Cremers et al, 2004) . Assuming all 5-HT 1A receptors to be in the high-affinity state, the calculated reduction in BP would be 82% after the 30-fold increase in 5-HT induced by fenfluramine and 58% after the 10-fold increase induced by the administration of ketanserin with citalopram. If all receptors would have been in the low-affinity state, the reduction in [ 18 F]MPPF binding would have been 9% after fenfluramine administration and 3% after the combination of ketanserin with citalopram. These data indicate that we would have seen an effect after the combination if a large proportion of the receptors would have been in the high-affinity state. Therefore, based on these calculations, we may conclude that the majority of 5-HT 1A receptors is in the low-affinity state.
Without Bonferroni correction, the combination of ketanserin and citalopram had a significant effect on [ 18 F]MPPF binding in the raphe nucleus, despite relatively small increases in 5-HT. This nucleus is very small and therefore the reduction may be a methodological artefact. However, other explanations are possible as well. In contrast to postsynaptic areas, in the raphe nucleus, a large proportion of receptors is located extrasynaptically (Kia et al, 1996) . We expect the major part of extrasynaptic 5-HT 1A receptors to be in the agonist high-affinity state (Udo de Haes et al, 2002) , and therefore 5-HT may have affected [
18 F]MPPF binding in this nucleus. The reduction in the raphe may also be due to internalization of the 5-HT 1A receptor after agonist stimulation. Riad et al (2004) has shown that presynaptic receptors are internalized after agonist stimulation, whereas postsynaptic receptors are not.
To summarize, we have shown that the administration of fenfluramine resulted in a significant reduction of [ 
